Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Healthtrust
Cantor Fitzgerald
McKesson
Mallinckrodt
AstraZeneca

Generated: April 25, 2019

DrugPatentWatch Database Preview

Darbepoetin alfa - Biologic Drug Details

« Back to Dashboard

Summary for darbepoetin alfa
Pharmacology for darbepoetin alfa
Ingredient-typeErythropoietin
Physiological EffectIncreased Erythroid Cell Production

US Patents for darbepoetin alfa

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source
Amgen ARANESP darbepoetin alfa VIAL; INTRAVENOUS 103951 001 2001-09-17 ➤ Try a Free Trial SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL) ➤ Try a Free Trial RX search
Amgen ARANESP darbepoetin alfa VIAL; INTRAVENOUS 103951 001 2001-09-17 ➤ Try a Free Trial ➤ Try a Free Trial RX search
Amgen ARANESP darbepoetin alfa VIAL; INTRAVENOUS 103951 001 2001-09-17 ➤ Try a Free Trial ➤ Try a Free Trial RX search
Amgen ARANESP darbepoetin alfa VIAL; INTRAVENOUS 103951 001 2001-09-17 ➤ Try a Free Trial YALE UNIVERSITY (New Haven, CT) ➤ Try a Free Trial RX search
Amgen ARANESP darbepoetin alfa VIAL; INTRAVENOUS 103951 001 2001-09-17 ➤ Try a Free Trial GENOSCIENCE PHARMA (Marseilles, FR) ➤ Try a Free Trial RX search
Amgen ARANESP darbepoetin alfa VIAL; INTRAVENOUS 103951 001 2001-09-17 ➤ Try a Free Trial ChemoCentryx, Inc. (Mountain View, CA) ➤ Try a Free Trial RX search
Amgen ARANESP darbepoetin alfa VIAL; INTRAVENOUS 103951 001 2001-09-17 ➤ Try a Free Trial THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (Philadelphia, PA) ➤ Try a Free Trial RX search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source

Subscribe to access the full database, or try a Free Trial

Supplementary Protection Certificates for darbepoetin alfa

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
0075 Netherlands ➤ Try a Free Trial PRODUCT NAME: DARBEPOETIN ALFA; REGISTRATION NO/DATE: EU/1/01/185/001 20010608
C0050 France ➤ Try a Free Trial PRODUCT NAME: DARBEPOETIN ALFA; REGISTRATION NO/DATE: EU/1/01/185/001 20010608
C028/2001 Ireland ➤ Try a Free Trial SPC028/2001: 20031204, EXPIRES: 20160607
43/2001 Austria ➤ Try a Free Trial PRODUCT NAME: DARBEPOETIN-ALFA
2004015 Lithuania ➤ Try a Free Trial PRODUCT NAME: DARBEPOETINAS ALFA (ASN30 THR32 VAL87 ASN88 THR90 EPO); REGISTRATION NO/DATE: EU/1/01/185/001-030 20010608
C/GB01/055 United Kingdom ➤ Try a Free Trial PRODUCT NAME: DARBEPOETIN ALFA; REGISTERED: UK EU/1/01/185/001-030 20010608
199059 Germany ➤ Try a Free Trial PRODUCT NAME: DARBEPOETIN ALFA; REGISTRATION NO/DATE: EU/1/01/185/001-030 20010608
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Fuji
Cipla
Mallinckrodt
Federal Trade Commission
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.